No Data
No Data
Little Excitement Around LAVA Therapeutics N.V.'s (NASDAQ:LVTX) Revenues As Shares Take 26% Pounding
Unfortunately for some shareholders, the LAVA Therapeutics N.V. (NASDAQ:LVTX) share price has dived 26% in the last thirty days, prolonging recent pain. The recent drop has obliterated the annual r
Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), LAVA Therapeutics (LVTX) and Crinetics Pharmaceuticals (CRNX)
JMP Securities Maintains LAVA Therapeutics(LVTX.US) With Buy Rating, Maintains Target Price $6
JMP Securities analyst Reni Benjamin maintains $LAVA Therapeutics(LVTX.US)$ with a buy rating, and maintains the target price at $6.According to TipRanks data, the analyst has a success rate of 35.5%
Analysts' Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), LAVA Therapeutics (LVTX) and Aura Biosciences Inc (AURA)
LAVA Therapeutics Narrows Losses, Grows Profit
LAVA Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)